In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Chen, Ying ^a   Zhou, Wenda ^a   Roh, Terrence ^a   Estes, Mary K ^b   Kaplan, David L ^a  

^a Tufts University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL CELL; CELL POLARITY; CELL POPULATION; CONTROLLED STUDY; ENTEROENDOCRINE CELL; ENZYME RELEASE; ESCHERICHIA COLI INFECTION; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE CELL; MICROVILLUS; NONHUMAN; OXYGEN TENSION; PANETH CELL; SMALL INTESTINE EPITHELIUM; TIGHT JUNCTION; UPREGULATION; BIOLOGICAL MODEL; CELL CULTURE; COCULTURE; IMMUNOLOGY; INTESTINE MUCOSA; SMALL INTESTINE; TISSUE SCAFFOLD;

CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; INTESTINE, SMALL; MODELS, BIOLOGICAL; TISSUE SCAFFOLDS;

EID: 85035781476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0187880     Document Type: Article

References (62)

1. Foster JA. Gut feelings: bacteria and the brain. Cerebrum. 2013; 2013:9. PMID: 24116266; PubMed Central PMCID: PMCPMC3788166.
2. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016; 14(1):20–32. https://doi.org/10.1038/nrmicro3552 PMID: 26499895; PubMed Central PMCID: PMCPMC4837114.
3. Sinagoga KL, Wells JM. Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J. 2015; 34(9):1149–63. https://doi.org/10.15252/embj.201490686 PMID: 25792515; PubMed Central PMCID: PMCPMC4426477.
4. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262–5. https://doi.org/10.1038/nature07935 PMID: 19329995.
5. Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol. 2015; 8(4):720–30. https://doi.org/10.1038/mi.2015.40 PMID: 25943273.
6. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015; 12 (12):720–7. https://doi.org/10.1038/nrgastro.2015.150 PMID: 26323879.
7. Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev. 2013; 19(1):1–13. https://doi.org/10.1089/ten.TEB.2012.0723 PMID: 23253031; PubMed Central PMCID: PMCPMC3564480.
8. Spurrier RG, Grikscheit TC. Tissue engineering the small intestine. Clin Gastroenterol Hepatol. 2013; 11(4):354–8. https://doi.org/10.1016/j.cgh.2013.01.028 PMID: 23380001.
9. Yu J, Carrier RL, March JC, Griffith LG. Three dimensional human small intestine models for ADME-Tox studies. Drug Discov Today. 2014; 19(10):1587–94. https://doi.org/10.1016/j.drudis.2014.05.003PMID: 24853950.
10. Balimane PV, Chong S. Cell culture-based models for intestinal permeability: a critique. Drug Discov Today. 2005; 10(5):335–43. https://doi.org/10.1016/S1359-6446(04)03354-9 PMID: 15749282.
11. Nikkhah M, Edalat F, Manoucheri S, Khademhosseini A. Engineering microscale topographies to control the cell-substrate interface. Biomaterials. 2012; 33(21):5230–46. https://doi.org/10.1016/j.biomaterials.2012.03.079 PMID: 22521491; PubMed Central PMCID: PMCPMC3619386.
12. Kim HJ, Ingber DE. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb). 2013; 5(9):1130–40. https://doi.org/10.1039/c3ib40126j PMID: 23817533.
13. Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016; 113(1):E7–15. https://doi.org/10.1073/pnas.1522193112 PMID: 26668389; PubMed Central PMCID: PMCPMC4711860.
14. Villenave R, Wales SQ, Hamkins-Indik T, Papafragkou E, Weaver JC, Ferrante TC, et al. Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro. PLoS One. 2017; 12(2): e0169412. https://doi.org/10.1371/journal.pone.0169412 PMID: 28146569; PubMed Central PMCID: PMCPMC5287454 Advisory Board. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
15. Deng X, Zhang G, Shen C, Yin J, Meng Q. Hollow fiber culture accelerates differentiation of Caco-2 cells. Appl Microbiol Biotechnol. 2013; 97(15):6943–55. https://doi.org/10.1007/s00253-013-4975-x PMID: 23689647.
16. Costello CM, Hongpeng J, Shaffiey S, Yu J, Jain NK, Hackam D, et al. Synthetic small intestinal scaffolds for improved studies of intestinal differentiation. Biotechnol Bioeng. 2014; 111(6):1222–32. https://doi.org/10.1002/bit.25180 PMID: 24390638; PubMed Central PMCID: PMCPMC4233677.
17. Chen Y, Lin Y, Davis KM, Wang Q, Rnjak-Kovacina J, Li C, et al. Robust bioengineered 3D functional human intestinal epithelium. Sci Rep. 2015; 5:13708. https://doi.org/10.1038/srep13708 PMID: 26374193; PubMed Central PMCID: PMCPMC4571649.
18. DeCicco RePass MA, Chen Y, Lin Y, Zhou W, Kaplan DL, Ward HD. Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum. Infect Immun. 2017; 85(3). https://doi.org/10.1128/IAI.00731-16 PMID: 28052996; PubMed Central PMCID: PMCPMC5328481.
19. Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res. 2002; 19(10):1400–16. PMID: 12425456.
20. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001; 46(1–3):27–43. PMID: 11259831.
21. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques. 2007; 43(5):575, 7–8, 81–2 passim. PMID: 18072586.
22. Sun H, Chow EC, Liu S, Du Y, Pang KS. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol. 2008; 4(4):395–411. https://doi.org/10.1517/17425255.4.4.395 PMID: 18433344.
23. Arrowsmith J. A decade of change. Nat Rev Drug Discov. 2012; 11(1):17–8. https://doi.org/10.1038/nrd3630 PMID: 22212671.
24. Castellanos-Gonzalez A, Cabada MM, Nichols J, Gomez G, White AC Jr. Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection. Infect Immun. 2013; 81 (6):1996–2001. https://doi.org/10.1128/IAI.01131-12 PMID: 23509153; PubMed Central PMCID: PMCPMC3676030.
25. Kauffman AL, Gyurdieva AV, Mabus JR, Ferguson C, Yan Z, Hornby PJ. Alternative functional in vitro models of human intestinal epithelia. Front Pharmacol. 2013; 4:79. https://doi.org/10.3389/fphar.2013.00079 PMID: 23847534; PubMed Central PMCID: PMCPMC3703544.
26. Holmberg FE, Seidelin JB, Yin X, Mead BE, Tong Z, Li Y, et al. Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. EMBO Mol Med. 2017; 9 (5):558–70. https://doi.org/10.15252/emmm.201607260 PMID: 28283650; PubMed Central PMCID: PMCPMC5412884.
27. Gjorevski N, Sachs N, Manfrin A, Giger S, Bragina ME, Ordonez-Moran P, et al. Designer matrices for intestinal stem cell and organoid culture. Nature. 2016; 539(7630):560–4. https://doi.org/10.1038/nature20168 PMID: 27851739.
28. In JG, Foulke-Abel J, Estes MK, Zachos NC, Kovbasnjuk O, Donowitz M. Human mini-guts: new insights into intestinal physiology and host-pathogen interactions. Nat Rev Gastroenterol Hepatol. 2016; 13(11):633–42. https://doi.org/10.1038/nrgastro.2016.142 PMID: 27677718; PubMed Central PMCID: PMCPMC5079760.
29. Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, de Jonge HR, et al. Human Enteroids/Colo-noids and Intestinal Organoids Functionally Recapitulate Normal Intestinal Physiology and Pathophysiology. J Biol Chem. 2016; 291(8):3759–66. https://doi.org/10.1074/jbc.R114.635995 PMID: 26677228; PubMed Central PMCID: PMCPMC4759158.
30. Schweinlin M, Wilhelm S, Schwedhelm I, Hansmann J, Rietscher R, Jurowich C, et al. Development of an Advanced Primary Human In Vitro Model of the Small Intestine. Tissue Eng Part C Methods. 2016; 22(9):873–83. https://doi.org/10.1089/ten.TEC.2016.0101 PMID: 27481569.
31. VanDussen KL, Marinshaw JM, Shaikh N, Miyoshi H, Moon C, Tarr PI, et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut. 2015; 64(6):911–20. https://doi.org/10.1136/gutjnl-2013-306651 PMID: 25007816; PubMed Central PMCID: PMCPMC4305344.
32. Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, et al. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016; 353(6306):1387–93. https://doi.org/10.1126/science.aaf5211 PMID: 27562956; PubMed Central PMCID: PMCPMC5305121.
33. Villar-Suarez V, Calles-Venal I, Bravo IG, Fernandez-Alvarez JG, Fernandez-Caso M, Villar-Lacilla JM. Differential Behavior Between Isolated and Aggregated Rabbit Auricular Chondrocytes on Plastic Surfaces. J Biomed Biotechnol. 2004; 2004(2):86–92. https://doi.org/10.1155/S1110724304312039 PMID: 15240918; PubMed Central PMCID: PMCPMC548807.
34. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci U S A. 1992; 89(19):9064–8. PMID: 1384042; PubMed Central PMCID: PMCPMC50065.
35. Antoni D, Burckel H, Josset E, Noel G. Three-dimensional cell culture: a breakthrough in vivo. Int J Mol Sci. 2015; 16(3):5517–27. https://doi.org/10.3390/ijms16035517 PMID: 25768338; PubMed Central PMCID: PMCPMC4394490.
36. Rockwood DN, Preda RC, Yucel T, Wang X, Lovett ML, Kaplan DL. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc. 2011; 6(10):1612–31. https://doi.org/10.1038/nprot.2011.379 PMID: 21959241; PubMed Central PMCID: PMCPMC3808976.
37. Lei NY, Jabaji Z, Wang J, Joshi VS, Brinkley GJ, Khalil H, et al. Intestinal subepithelial myofibroblasts support the growth of intestinal epithelial stem cells. PLoS One. 2014; 9(1):e84651. https://doi.org/10.1371/journal.pone.0084651 PMID: 24400106; PubMed Central PMCID: PMCPMC3882257.
38. Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, et al. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol. 2015; 90(1):43–56. https://doi.org/10.1128/JVI.01930-15 PMID: 26446608; PubMed Central PMCID: PMCPMC4702582.
39. Hosseinkhani M, Mehrabani D, Karimfar MH, Bakhtiyari S, Manafi A, Shirazi R. Tissue engineered scaffolds in regenerative medicine. World J Plast Surg. 2014; 3(1):3–7. PMID: 25489516; PubMed Central PMCID: PMCPMC4236978.
40. Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan DL. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials. 2005; 26(34):7082–94. https://doi.org/10.1016/j.biomaterials.2005.05.022 PMID: 15985292.
41. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A. 2004; 71(3):528–37. https://doi.org/10.1002/jbm.a.30186 PMID: 15478212.
42. Abbott RD, Wang RY, Reagan MR, Chen Y, Borowsky FE, Zieba A, et al. The Use of Silk as a Scaffold for Mature, Sustainable Unilocular Adipose 3D Tissue Engineered Systems. Adv Healthc Mater. 2016; 5(13):1667–77. https://doi.org/10.1002/adhm.201600211 PMID: 27197588; PubMed Central PMCID: PMCPMC4982640.
43. Wagner BA, Venkataraman S, Buettner GR. The rate of oxygen utilization by cells. Free Radic Biol Med. 2011; 51(3):700–12. https://doi.org/10.1016/j.freeradbiomed.2011.05.024 PMID: 21664270; PubMed Central PMCID: PMCPMC3147247.
44. Creamer B, Shorter RG, Bamforth J. The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut. 1961; 2:110–8. PMID: 13696345; PubMed Central PMCID: PMCPMC1413255.
45. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014; 12(10):661–72. https://doi.org/10.1038/nrmicro3344 PMID: 25198138.
46. Taylor CT, Colgan SP. Hypoxia and gastrointestinal disease. J Mol Med (Berl). 2007; 85(12):1295–300. https://doi.org/10.1007/s00109-007-0277-z PMID: 18026919.
47. Bohlen HG. Intestinal mucosal oxygenation influences absorptive hyperemia. Am J Physiol. 1980; 239 (4):H489–H93. Epub 1980/10/01. PMID: 7425141.
48. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011; 6(3):209–40. https://doi.org/10.1007/s12263-011-0229-7PMID: 21617937; PubMed Central PMCID: PMCPMC3145058.
49. Morgan ME, Koelink PJ, Zheng B, den Brok MH, van de Kant HJ, Verspaget HW, et al. Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis. Mucosal Immunol. 2014; 7(5):1266–77. https://doi.org/10.1038/mi.2014.16 PMID: 24670426; PubMed Central PMCID: PMCPMC4137742.
50. Brown M, Hughes KR, Moossavi S, Robins A, Mahida YR. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease. Clin Exp Immunol. 2014; 178(1):28–39. https://doi.org/10.1111/cei.12381 PMID: 24828022; PubMed Central PMCID: PMCPMC4231243.
51. Sidoroff M, Karikoski R, Raivio T, Savilahti E, Kolho KL. High-sensitivity C-reactive protein in paediatric inflammatory bowel disease. World J Gastroentero. 2010; 16(23):2901–6. https://doi.org/10.3748/wjg.v16.i23.2901 WOS:000279034500009. PMID: 20556836
52. Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, Xu H, et al. Activation of an IL-6:STAT3-depen-dent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14 (4):446–57. https://doi.org/10.1002/ibd.20342 PMID: 18069684; PubMed Central PMCID: PMCPMC2581837.
53. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003; 38(2):180–5. https://doi.org/10.1080/ 00365520310000672 PMID: 12678335.
54. Sideri A, Bakirtzi K, Shih DQ, Koon HW, Fleshner P, Arsenescu R, et al. Substance P mediates proinflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients. Cell Mol Gastroenterol Hepatol. 2015; 1(4):420–32. https://doi.org/10.1016/j.jcmgh.2015.03.003 PMID: 26543894; PubMed Central PMCID: PMCPMC4629258.
55. Puleston J, Cooper M, Murch S, Bid K, Makh S, Ashwood P, et al. A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 21(2):109–20. https://doi.org/10.1111/j.1365-2036.2004.02262.x PMID: 15679760.
56. Vasseur F, Sendid B, Jouault T, Standaert-Vitse A, Dubuquoy L, Francois N, et al. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn’s disease and anti-saccharo-myces cerevisiae antibody levels. Inflamm Bowel Dis. 2012; 18(3):430–8. https://doi.org/10.1002/ibd.21817 PMID: 21739538.
57. Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, et al. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis. 2007; 13(6):727–32. https://doi.org/10.1002/ibd.20107 PMID: 17260368.
58. Arijs I, De Hertogh G, Lemaire K, Quintens R, Van Lommel L, Van Steen K, et al. Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One. 2009; 4(11):e7984. https://doi.org/10.1371/journal.pone.0007984 PMID: 19956723; PubMed Central PMCID: PMCPMC2776509.
59. Martinez-Medina M, Garcia-Gil LJ. Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity. World J Gastrointest Pathophysiol. 2014; 5 (3):213–27. https://doi.org/10.4291/wjgp.v5.i3.213 PMID: 25133024; PubMed Central PMCID: PMCPMC4133521.
60. Liu F, Huang J, Ning B, Liu Z, Chen S, Zhao W. Drug Discovery via Human-Derived Stem Cell Organoids. Front Pharmacol. 2016; 7:334. https://doi.org/10.3389/fphar.2016.00334 PMID: 27713700; PubMed Central PMCID: PMCPMC5032635.
61. Foulke-Abel J, In J, Yin JY, Zachos NC, Kovbasnjuk O, Estes MK, et al. Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology. Gastroenterology. 2016; 150 (3):638–+. https://doi.org/10.1053/j.gastro.2015.11.047 WOS:000370648100025. PMID: 26677983
62. Ribet D, Cossart P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 2015; 17(3):173–83. https://doi.org/10.1016/j.micinf.2015.01.004 WOS:000351106800002. PMID: 25637951